Lead aVR: Dead or Simply Forgotten?⁎⁎Editorials published in JACC: Cardiovascular Imaging reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College of Cardiology.  by Vorobiof, Gabriel & Ellestad, Myrvin H.
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 4 , N O . 2 , 2 0 1 1
© 2 0 1 1 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 0 . 1 1 . 0 1 1E D I T O R I A L C O M M E N T
Lead aVR: Dead or Simply Forgotten?*
Gabriel Vorobiof, MD,†‡ Myrvin H. Ellestad MD†





































aThe only truly dead are those who have been
forgotten.
—Jewish proverb (1)
The history of our recognition that exercise pro-
duces ischemia may go back nearly 100 years, to
when Bousfield (2) demonstrated ST-segment
changes during a spontaneous anginal attack and
later, when Feil and Siegel (3) reported that exer-
cised patients with angina developed ST-segment
and T-wave changes. To study the electric forces
generated within the cardiac chambers during the
propagation of cardiac impulses, it is necessary to
See page 176
attach electrodes to the heart or to the surface of the
body (4). Electrocardiographic lead aVR is, by
definition, an augmented, indirect, and unipolar
limb lead directed at 150° on Einthoven’s original
axis triangle and reflects the averaged vector of
negative lead I (180°) and positive lead II (60°)
(5). Lead aVR, also referred to as “no man’s land” or
“the orphan lead,” is directed downward and into
the left ventricular cavity from above and therefore
is thought to reflect basal interventricular septal
ischemia (4,6). Lead aVR was originally con-
structed to obtain information on the electrical
changes as viewed from the upper right side of the
heart to include the right ventricular outflow tract
and interventricular septum (6). The site of electro-
cardiographic ST-segment depression does not typ-
ically correlate with the ischemic territory, although
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relationships to disclose.his can be improved by simultaneous myocardial
erfusion imaging (MPI) (7,8). The utility of lead
VR goes beyond the evaluation of coronary artery
isease (CAD) and has been demonstrated in a
ariety of clinical situations, such as pericarditis,
ulmonary embolism, tricyclic antidepressant tox-
city, tension pneumothorax, stress-induced cardio-
yopathy, and as a means of differentiating atrial
achyarrhythmias.
ead aVR and Acute Coronary Syndromes
T-segment elevation (STE), widely used in clini-
al practice to localize myocardial systolic injury
urrent in all other leads, is often ignored in lead
VR (9). This is believed to be because most of the
hanges seen in lead aVR are largely redundant, as
any clinicians believe that they represent recipro-
al changes from leads aVL, II, V5, and V6. STE
as been identified as a harbinger of poor prognosis
n the setting of acute myocardial infarction, and its
rompt identification and early aggressive surgical
anagement improve clinical outcomes (10,11).
he presence of STE in lead aVR greater than STE
n lead V1 is 81% sensitive, 80% specific, and has
1% overall accuracy for the prediction of acute left
ain coronary artery obstruction (10). When com-
ined with positive initial cardiac troponin T, STE
n lead aVR is a predictor of adverse cardiac events
nd can serve as a useful clinical tool for the risk
tratification of patients with non-STE myocardial
nfarction (12). Analysis of the GRACE (Global
egistry of Acute Coronary Events) registry dem-
nstrates that STE in lead aVR did not provide
ncremental prognostic value beyond the standard
RACE risk model. However, for patients who
nderwent coronary catheterization (n  2,416),
he prevalence of left main or 3-vessel disease was
ound to be 56% in those with STE 1 mm in lead
VR (13). Clearly, STE in lead aVR is an important
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188formation in the setting of unstable coronary syn-
dromes.
Lead aVR and Exercise Stress Testing
STE in lead aVR is not an uncommon finding on
exercise treadmill tests, with a reported incidence of
10% to 25% (14–16). Fewer data exist on the utility
and performance of STE in lead aVR during
exercise stress testing than in the setting of acute
coronary syndromes. Nevertheless, the association
of STE in lead aVR has been shown to have
excellent sensitivity of 93% and modest specificity
of 49% for the detection of 50% stenosis in the
eft main coronary artery in patients with Duke
readmill scores  11. Importantly, specificity is
mproved to 82% when STE in lead aVR is accom-
anied by STE in lead V1 (17). A similar study
confirmed the modest specificity of isolated STE in
lead aVR for significant left main disease on coro-
nary angiography to be 50%, sensitivity to be 85%,
positive predictive value to be 26%, and negative
predictive value to be 94% (15). The presence of
exercise-induced STE in lead aVR concomitant
with ST-segment depression in lead V5 has also
een shown to occur in 81% of patients subse-
uently found to have significant left anterior
escending coronary artery (LAD) disease (18)
nd in 85% of those with 2-vessel disease (most
ommonly in the LAD and the right coronary
rtery) (16).
What remains unresolved is what percent of
atients has STE in lead aVR who did not have
ignificant left main or LAD stenosis (i.e., the true
pecificity of this finding). Another problematic
ssue is that all of these studies used purely anatomic
efinitions from coronary angiography to define
emodynamic significance. Fractional flow reserve,
he current gold standard for physiological interro-
ation of coronary lesions, provides superior func-
ional evaluation and results in improved long-term
linical outcomes (19).
Overall, however, it appears that STE in lead
VR during exercise testing is a valuable and sen-
itive but nonspecific marker for left main or prox-
mal LAD disease. Neglect of lead aVR is unfortu-
ately reinforced by the 2002 American College of
ardiology and American Heart Association exer-
ise testing guidelines, which disregard the role of
TE in lead aVR in the interpretation of exercise-nduced ischemic changes (20).Lead aVR and Myocardial Perfusion Imaging
Stress radionuclide single photon-emission com-
puted tomography (SPECT) MPI is a well-
validated diagnostic procedure for the assessment of
patients with known or suspected CAD. It has high
sensitivity for the detection of flow-limiting coro-
nary stenosis and provides incremental prognostic
information that contributes to risk stratification
and guides clinical decision making with regard to
management and therapeutic interventions. Find-
ings on SPECT MPI that could potentially indicate
significant left main disease include inducible de-
crease in tracer activity in LAD and left circumflex
coronary artery distribution (the “left main pat-
tern”), multivessel perfusion abnormalities, single-
vessel perfusion abnormalities and nonperfusion
abnormalities such as transient ischemic dilation,
electrocardiographic changes, and increased radio-
tracer lung uptake. The performance of SPECT
MPI to detect isolated left main coronary disease
was recently evaluated with results indicating that in
19% of patients with angiographically proven left
main disease, no perfusion defects were visible on
MPI (21). However, improved MPI sensitivity for
the detection of left main disease can be achieved by
adding attenuation correction to the SPECT MPI
protocol (22) or by paying attention to nonperfu-
sion variables (such as transient ischemic dilation
and ST-segment changes) (23). In fact, STE in lead
aVR appears to be predictive (odds ratio: 2.77; p 
.008) of reversible anterior wall perfusion defects
n SPECT MPI, even after adjustment for ST-
egment depression in the chest leads (14).
More recently, 82Rb positron emission tomogra-
phy MPI has been shown, by permitting the quan-
tification of maximal rest and stress left and right
ventricular uptake, to independently and incremen-
tally identify patients with left main or 3-vessel
coronary disease (24).
The Present Study
In this issue of iJACC, Uthamalingam et al. (25)
report on the use of STE in lead aVR during
exercise treadmill SPECT MPI and its relation to
obstructive left main or ostial LAD CAD. They
report that stress-induced STE  1 mm in lead
aVR increases the post-test probability of left main
stenosis and is the single best predictor after mul-
tivariate analysis. Specifically, they found STE in
lead aVR to have sensitivity of 75%, specificity of
81%, and overall accuracy of 80% for detecting
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189They enrolled consecutive patients undergoing car-
diac catheterization who had either left main or
ostial LAD disease (50% luminal diameter reduc-
tion) with or without other lesions 70% luminal
diameter reduction (n  74) and those with ob-
structive CAD (70% luminal diameter reduction)
without left main or ostial LAD disease (n  264).
Importantly, the gold standard estimation of
“significance” of coronary disease in this study (and
many others) relied solely on visually estimated
luminal diameters by coronary angiography, a
method widely believed to have high interobserver
variability and poor correlation with physiological
parameters of hemodynamic significance such as
fractional flow reserve (26–28). Therefore, it is
inaccurate to deem all 50% stenoses within the
left main and/or ostial LAD “hemodynamically
significant.” To their credit, the investigators ac-
knowledge this as a known limitation in their study;
however, this is not necessarily a specific limitation
of this study alone, but one of many that appear in
the published research. Notably, other important
clinical markers that were independently predictive
included reversible LAD ischemia on MPI and
post-stress left ventricular ejection fraction. STE or
ST-segment depression in no other single lead was
found to have predictive power after multivariate
analysis.
What appears from this report, and ones before
it, is that STE in lead aVR does not appear to be an1355–6.
1
1
2001;38:1348–54.ostial LAD lesions, but rather, is present in increas-
ing frequency with higher burdens of CAD. As
such, STE in lead aVR was found in the present
study to be present in 39% of patients with 3-vessel
CAD, 27% of patients with 2-vessel CAD, and
17% of patients with 1-vessel CAD, all without left
main and/or ostial LAD. This begs several ques-
tions: is STE in lead aVR a specific marker that is
unique to left main and/or ostial LAD, or does it
represent a more global myocardial process, as
reflected by its increasing frequency with increasing
coronary vessel involvement of CAD? Does a 25%
false-negative rate (sensitivity 75%) and a 19% false
positive rate (specificity 81%) justify its use during
routine exercise stress tests, or should it be incor-
porated into more complex scoring algorithms that
may perform with greater accuracy? Should STE in
lead aVR always trump normal MPI findings, or
should we place a lesser focus on lead aVR when
MPI variables are unrevealing? Conversely, can
patients with anterior ischemia on MPI and an
absence of STE in lead aVR be reassured as to the
low likelihood of left main and/or ostial LAD
disease? The answers to these questions are ripe for
investigation.
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